increased cardiac muscle glycogen level_Tg(Myh6-PRKAG2*R531G)22Dca/0

http://metadb.riken.jp/0014071IC57BL10CBACaTgMyh6PRKAG2R531G22Dca0TgMyh6PRKAG2R531G22Dca

increased cardiac muscle glycogen level_Tg(Myh6-PRKAG2*R531G)22Dca/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 22, David Carling
  http://metadb.riken.jp/db/mgi_rdf/MGI:3688829

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-PRKAG2*R531G)22Dca/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-PRKAG2*R531G)22Dca

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/10 * CBA/Ca

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• http://purl.obolibrary.org/obo/MP_0014071

文献

http://purl.org/net/cito/citesAsAuthority

• Joanna K. Davies, et.al., Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome., American journal of physiology. Heart and circulatory physiology, 2006, 290
  http://rdf.ncbi.nlm.nih.gov/pubmed/16339829